By Karen Roman
Agilent Technologies, Inc. (NYSE: A) said it opened Biopharma CDx Services Lab in Carpinteria, California.
The laboratory will contribute to drug development, therapeutics and precision medicine, as well as early clinical studies through regulatory approval, it said in a statement.
“By providing cutting-edge technologies and high-quality assays, Agilent aims to streamline the path from early clinical studies to FDA approval, accelerating the delivery of life-changing treatments to patients,” said Nina Green, vice president of Agilent’s Companion Diagnostics (CDx) Division.
Contact:
Editor@executives-edge.com
